Trial Profile
A retrospective study to evaluate the association between glycemia during radiotherapy plus temozolomide therapy and overall survival in patients with newly diagnosed glioblastoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 10 May 2016 New trial record